Cytora Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
66
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
14
Cytora General Information
Description
Developer of a risk digitization and analytics platform designed to streamline key business processes including clearance, accumulation management, and cross-selling. transform underwriting for commercial insurance. The company's platform focuses on leveraging artificial intelligence to learn the patterns of different risks and loss outcomes over time and computes a rank, score, and price for every property and organization, enabling insurers to target the profitable risks, augmenting with internal and external data sources, improve risk selection as well as pricing.
Contact Information
Website
www.cytora.com(Operating Subsidiary)
Corporate Office
- 6th Floor One London Wall
- Barbican
- London EC2Y 5EB
- England, United Kingdom
Corporate Office
- 6th Floor One London Wall
- Barbican
- London EC2Y 5EB
- England, United Kingdom
Cytora Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cytora Comparisons
Industry
Financing
Details
Cytora Competitors (24)
One of Cytora’s 24 competitors is Federato, a Venture Capital-Backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Federato | Venture Capital-Backed | Palo Alto, CA | ||||
| Scienaptic | Venture Capital-Backed | New York, NY | ||||
| EIS Group Software | Formerly PE-Backed | San Francisco, CA | ||||
| Insurity | Private Equity-Backed | Hartford, CT | ||||
| Acturis Group | Private Equity-Backed | London, United Kingdom |
Cytora Patents
Cytora Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12115196-B1 | Methods for treating neurological diseases | Active | 26-Sep-2023 | ||
| AU-2024317601-A1 | Cryopreserving composition comprising stem cells | Pending | 31-Jul-2023 | ||
| EP-4754233-A1 | Cryopreserving composition comprising stem cells | Pending | 31-Jul-2023 | ||
| WO-2025027593-A1 | Cryopreserving composition comprising stem cells | Inactive | 31-Jul-2023 | ||
| AU-2024293323-A1 | Methods for treating neurological diseases | Pending | 20-Jul-2023 | A61K35/38 |
Cytora Signals
Cytora Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cytora FAQs
-
When was Cytora founded?
Cytora was founded in 2012.
-
Where is Cytora headquartered?
Cytora is headquartered in London, United Kingdom.
-
What is the size of Cytora?
Cytora has 66 total employees.
-
What industry is Cytora in?
Cytora’s primary industry is Financial Software.
-
Is Cytora a private or public company?
Cytora is a Private company.
-
What is Cytora’s current revenue?
The current revenue for Cytora is .
-
How much funding has Cytora raised over time?
Cytora has raised $43.2M.
-
Who are Cytora’s investors?
Accelerate Cambridge, Adfisco, , Cambridge Angels, and Cambridge Enterprise Ventures are 5 of 22 investors who have invested in Cytora.
-
Who are Cytora’s competitors?
Federato, Scienaptic, EIS Group Software, Insurity, and Acturis Group are some of the 24 competitors of Cytora.
-
When was Cytora acquired?
Cytora was acquired on 09-Sep-2025.
-
Who acquired Cytora?
Cytora was acquired by Applied Systems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process